If you are losing weight steadily, stay at your current dose more is not always better
The researchers found no difference between subcutaneous and oral semaglutide for constipation
The STEP program encompasses five phase 3 trials that focus on the different aspects of weight management, including weight management in type 2 diabetes, weight management with intensive behavioral therapy, sustained weight management, and long-term weight management
Ozempic Ozempic was the first semaglutide formulation to receive FDA approval in 2017
Clinical trial safety data: In the Phase 2 trial, adverse events were comparable to placebo
Step 2: Choose & clean your injection site Select an area of skin with adequate subcutaneous fat in your abdomen, thigh, or upper arm